Danimer Scientific — FY2021 Earnings Presentation
15 slides from Danimer Scientific's earnings presentation, Feb 28, 2022
Slide 1: Fourth Quarter & Full Year 2021 Earnings Presentation
Fourth Quarter & Full Year 2021 Earnings Presentation February 28, 2022
Slide 2: Disclaimer
Disclaimer This presentation (“Presentation”) is for informational purposes only . This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitati
Slide 3: Danimer's Strategic Priorities
Danimer’s Strategic Priorities 3 Expand Capacity to Achieve Scale 1 2 3 4 5 6 Lead with Innovation to Address a Broad Range of Customer Needs Grow Customer Partnerships and Product Volume Commitments Secure Cost - Effective Inputs Attain Favorable Unit Economics to Enhance Margins Enhance Team Capab
Slide 4: Expand Capacity: Kentucky Facility Update
Expand Capacity: Kentucky Facility Update 4 Facility Expansion Update: Phase I (Completed 2020): $57mm of construction costs, ~20mm lbs. of Nodax - based finished product, annually Phase II broke ground in December 2020 with start - up expected in Q2 2022E ~$128mm in total construction costs e
Slide 5: Expand Capacity: Bainbridge Greenfield Facility Update - Possible Schedule Change
Expand Capacity: Bainbridge Greenfield Facility Update - Possible Schedule Change 5 Greenfield Facility Overview Commentary Greenfield Rendering Location of Greenfield site selected in Georgia due to better utilities rates and incentives Broke ground in November 2021 and civil engineering work i
Slide 6: Expand Capacity: PHA-Based Resin Capacity – Pre Rinnovo
Expand Capacity: PHA - Based Resin Capacity – Pre Rinnovo 6 Kentucky 32.5M lbs of Nodax Georgia Greenfield 62.5M lbs of Nodax Purchased Raw Material 95M lbs Purchased Materials Danimer Danimer 65M lbs of PHA - based resin 125M lbs of PHA - based resin 190M lbs of PHA - based Resin from KY and GA
Slide 7: Expand Capacity: PHA-Based Resin Capacity – Including Rinnovo Plant
Expand Capacity: PHA - Based Resin Capacity – Including Rinnovo Plant 7 Kentucky 32.5M lbs of Nodax Georgia Greenfield 62.5M lbs of Nodax Purchased Raw Material 127M lbs Rinnovo Plant 168M lbs of Rinnovo 330M lbs of PHA - based Resin from KY and GA 60M lbs of Standalone Rinnovo (2) Purchased Materia
Slide 8: Recent Customer Partnerships & Business Development Initiatives
Recent Customer Partnerships & Business Development Initiatives 8 R&D agreement with Bacardi to design and develop a PHA based spirit bottle Joint R&D to design, develop, manufacture and evaluate PHA based resins for individual layers suitable for flexible food packaging Research & Development
Slide 9: 2021 ESG Report
2021 ESG Report 9 ALIGNMENT WITH THE U.N. SUSTAINABLE DEVELOPMENT GOALS 1 Notes: 1 - Numbered boxes shown above represent specific UN Sustainability Development Goals.
Slide 10: Q4 & Full Year 2021 Financial Summary
Q4 & Full Year 2021 Financial Summary 10 PHA increased to 50% of revenue vs 19% in Q4 2020 Costs influenced by: ‒ Elevated fixed - cost absorption at our Kentucky Facility as we scale up production ‒ Investments in headcount and salaries to support future expansion plans ‒ Public company costs ‒
Slide 11: Forward Catalysts
Forward Catalysts 11 Continued focus on driving operational costs down as we scale production Large and growing TAM Believed to be the only PHA product offering at commercial scale production Increasing governmental regulations on single - plastic uses Demand from blue chip multinational c
Slide 12: Danimer is a Next Generation Bioplastics Company
Danimer is a Next Generation Bioplastics Company ` Experienced Leadership Team and Board of Directors with Proven Track Record 6 Significant Tailwinds From Increased Corporate and Legislative Initiatives on Environmental Impact of Global Pollution Crisis 2 Highly Attractive PHA Technology Serves as
Slide 13: danimer ~
danimer ~ scientific ‘entific
Slide 14: Adjusted EBITDA Reconciliation
$MM 4Q'21 4Q'20 12/31/2021 12/31/2020 Net Loss ($12.446) ($3.233) ($60.107) ($8.853) Income tax expense (benefit) ($1.810) $0.000 ($13.233) $0.000 Interest expense, net $0.247 $0.910 $0.763 $2.080 Depreciation and amortization $4.185 $1.820 $11.674 $4.609 Remeasurement of private warrants ($21.332)
Slide 15: Adjusted Gross Profit Reconciliation
Adjusted Gross Profit Reconciliation 15 Note: Totals may not foot due to rounding. ALL AMOUNTS PRELIMINARY AND UNAUDITED $MM 4Q'21 4Q'20 12/31/2021 12/31/2020 Total Revenue $17.728 $12.027 $58.749 $47.333 Cost of Revenue $20.080 $10.818 $57.865 $35.876 Gross Profit ($2.351) $1.209 $0.884 $11.457 Dep